GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poxel SA (XPAR:POXEL) » Definitions » Gross Margin %

Poxel (XPAR:POXEL) Gross Margin % : 0.34% (As of Dec. 2022)


View and export this data going back to 2015. Start your Free Trial

What is Poxel Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Poxel's Gross Profit for the six months ended in Dec. 2022 was €0.00 Mil. Poxel's Revenue for the six months ended in Dec. 2022 was €0.59 Mil. Therefore, Poxel's Gross Margin % for the quarter that ended in Dec. 2022 was 0.34%.


The historical rank and industry rank for Poxel's Gross Margin % or its related term are showing as below:


XPAR:POXEL's Gross Margin % is not ranked *
in the Biotechnology industry.
Industry Median: 60.53
* Ranked among companies with meaningful Gross Margin % only.

Poxel had a gross margin of 0.34% for the quarter that ended in Dec. 2022 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Poxel was 0.00% per year.


Poxel Gross Margin % Historical Data

The historical data trend for Poxel's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poxel Gross Margin % Chart

Poxel Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 99.57 0.30

Poxel Semi-Annual Data
Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 52.85 - 0.34

Competitive Comparison of Poxel's Gross Margin %

For the Biotechnology subindustry, Poxel's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Poxel's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Poxel's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Poxel's Gross Margin % falls into.



Poxel Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Poxel's Gross Margin for the fiscal year that ended in Dec. 2022 is calculated as

Gross Margin % (A: Dec. 2022 )=Gross Profit (A: Dec. 2022 ) / Revenue (A: Dec. 2022 )
=0 / 0.674
=(Revenue - Cost of Goods Sold) / Revenue
=(0.674 - 0.672) / 0.674
=0.30 %

Poxel's Gross Margin for the quarter that ended in Dec. 2022 is calculated as


Gross Margin % (Q: Dec. 2022 )=Gross Profit (Q: Dec. 2022 ) / Revenue (Q: Dec. 2022 )
=0 / 0.591
=(Revenue - Cost of Goods Sold) / Revenue
=(0.591 - 0.589) / 0.591
=0.34 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Poxel  (XPAR:POXEL) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Poxel had a gross margin of 0.34% for the quarter that ended in Dec. 2022 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Poxel Gross Margin % Related Terms

Thank you for viewing the detailed overview of Poxel's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Poxel (XPAR:POXEL) Business Description

Traded in Other Exchanges
Address
259/261 Avenue Jean Jaures, Immeuble le Sunway, Lyon, FRA, 69007
Poxel SA is a biopharmaceutical company. It is focused on the development of novel treatments for metabolic diseases, including type 2 diabetes and liver diseases, such as nonalcoholic steatohepatitis (NASH) and rare disorders (ALD/AMN). It has developed a portfolio of drug candidates, including its candidates: Imeglimin, for the treatment of type 2 diabetes, and PXL770 and PXL065, for the treatment of NASH.

Poxel (XPAR:POXEL) Headlines

No Headlines